STOCK TITAN
  1. Home
  2. News
  3. IQV

Iqvia Hldgs Inc - IQV STOCK NEWS

Welcome to our dedicated page for Iqvia Hldgs news (Ticker: IQV), a resource for investors and traders seeking the latest updates and insights on Iqvia Hldgs stock.

IQVIA Holdings Inc. (IQV) delivers integrated healthcare insights through its unique combination of clinical research expertise and advanced data analytics. This news hub provides investors and industry professionals with timely updates on corporate developments shaping the life sciences sector.

Access official press releases and curated news coverage spanning clinical trial milestones, healthcare data partnerships, regulatory updates, and technology innovations. Our collection serves as a strategic resource for understanding IQVIA's role in optimizing drug development cycles and commercial decision-making.

Key content categories include earnings announcements, merger/acquisition activity, leadership changes, and analytical breakthroughs in real-world evidence applications. Bookmark this page for efficient tracking of IQVIA's progress in transforming clinical research through data-driven solutions.

News

IQVIA Digital Enablement Named PM360 Trailblazer 2023 Supplier/Vendor of the Year

Rhea-AI Summary
IQVIA (NYSE:IQV) has been named a PM360 Trailblazer 2023 Company of the Year in the Supplier/Vendor category for its Digital Enablement division. The award recognizes outstanding achievement and innovation in healthcare marketing, with a focus on innovation, talent development, and social responsibility.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.33%
Tags
none
-
News

IQVIA CFO Ron Bruehlman to Speak at Evercore HealthCONx Conference on November 29, 2023

Rhea-AI Summary
IQVIA Holdings Inc. (IQV) announced that Ron Bruehlman, executive vice president and chief financial officer, will speak at the Evercore Annual HealthCONx Conference in Miami on November 29, 2023, at 10:50 a.m. ET. A live audio webcast of the presentation will be available on the IQVIA Investor Relations website at http://ir.iqvia.com, with a replay available later that day.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1%
Tags
conferences
-
News

IQVIA Announces Upsizing of its Allocation of New Term B Loans

Rhea-AI Summary
IQVIA Holdings Inc. (NYSE:IQV) announces allocation of a new term B loan due 2031 of approximately $1,500 million, upsized due to lender demand. The loan, along with senior secured notes, will be used to repay existing loans and related fees. The Company also entered into a cross-currency swap agreement to hedge exposure to USD-denominated indebtedness, resulting in an effective net borrowing rate of 4.9015%.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
none
News

IQVIA Announces Pricing of Upsized Offering of Senior Secured Notes

Rhea-AI Summary
IQVIA Holdings Inc. (NYSE:IQV) announces the pricing of $1,250 million in senior secured notes due 2029, which was upsized due to strong demand. The proceeds will be used to repay outstanding term loans and pay fees and expenses related to the offering and credit agreement amendment.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.67%
Tags
none
-
News

IQVIA Announces Offering of Senior Secured Notes

Rhea-AI Summary
IQVIA Holdings Inc. (NYSE:IQV) Announces Intent to Raise $500 Million through Notes Offering and Amend Credit Facilities. The proceeds will be used to repay outstanding term loans and pay related fees and expenses. The offering is subject to market conditions and customary terms.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
3.52%
Tags
none
-
News

IQVIA’s Christina Mack Named 2023 PharmaVoice 100 Honoree

Rhea-AI Summary
IQVIA, a global provider of data and analytics to the life sciences industry, announced that Dr. Christina Mack, chief scientific officer, has been named to the 2023 PharmaVoice 100 list. The list recognizes leaders who have made significant contributions to the industry and improved the lives of patients.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.61%
Tags
none
News

IQVIA Reports Third-Quarter 2023 Results

Rhea-AI Summary
IQVIA Holdings Inc. reported Q3 2023 financial results with revenue of $3,736 million, a 4.9% YoY increase. GAAP Net Income grew 7.1% YoY to $303 million. R&D Solutions quarterly bookings reached $2.6 billion with a book-to-bill ratio of 1.24x. The contracted backlog grew 12% YoY to $28.8 billion. Adjusted EBITDA increased 9.1% YoY to $888 million. The company updated its full-year guidance with a revenue growth range of 3.3% to 3.5%.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.45%
Tags
earnings
-
News

IQVIA to Provide Sanofi Its Orchestrated Customer Engagement (OCE) Platform in Africa & Middle East

Rhea-AI Summary
Sanofi will use IQVIA's CRM platform to maximize customer interactions and innovate in the retail channel.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.35%
Tags
none
-
News

IQVIA and CEPI Collaborate to Strengthen Global Research Preparedness to Advance the 100 Days Mission

Rhea-AI Summary
CEPI and IQVIA announce strategic collaboration to advance the 100 Days Mission and strengthen global clinical research for vaccines and biological countermeasures against emerging infectious diseases.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.51%
Tags
none
News

IQVIA to Announce Third-Quarter 2023 Results on November 1, 2023

Rhea-AI Summary
IQVIA Holdings Inc. will announce its Q3 2023 financial results on November 1, 2023.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.99%
Tags
earnings
Stock IQV logo
Iqvia Hldgs Inc

NYSE:IQV

IQV Rankings

N/A Ranked by Market Cap
N/A Ranked by Dividends

IQV Stock Data

25.37B
174.77M
0.88%
95.89%
1.99%
Diagnostics & Research
Services-commercial Physical & Biological Research
Link
United States
DURHAM